Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.685
+0.055 (1.19%)
At close: Mar 13, 2026
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.69 billion as of March 13, 2026. Its market cap has increased by 115.40% in one year.
Market Cap
1.69B
Enterprise Value
1.48B
Revenue
100.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.69
Market Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.69B, an increase of 262.85%. That is a compound annual growth rate of 61.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.69B | -8.92% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.14B |
| ArcticZymes Technologies ASA | 1.10B |
| Nykode Therapeutics AS | 969.84M |
| Lytix Biopharma AS | 811.30M |
| Zelluna ASA | 467.60M |
| SoftOx Solutions AS | 183.63M |
| EXACT Therapeutics AS | 139.18M |
| Arctic Bioscience AS | 91.65M |